PRICE T ROWE ASSOCIATES INC /MD/ - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 88 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$10,0000.0%43,337
+53.3%
0.00%
Q4 2021$10,000
-41.2%
28,266
+2.2%
0.00%
Q3 2021$17,000
-41.4%
27,657
+5.3%
0.00%
Q2 2021$29,00026,2570.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2021
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 432,503$554,0000.09%
MONECO Advisors, LLC 35,000$45,0000.02%
Purus Wealth Management, LLC 15,000$19,0000.02%
Renaissance Technologies 8,454,364$10,822,0000.01%
LMR Partners LLP 390,864$500,0000.01%
ExodusPoint Capital Management, LP 595,459$762,0000.01%
LINCOLN CAPITAL CORP 12,000$15,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 264,500$339,0000.01%
HRT FINANCIAL LP 347,816$445,0000.01%
FIRST MIDWEST BANK TRUST DIVISION 25,000$32,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders